Latest Manufacturing News

Nanoveu Limited advances its proprietary 16nm ECS-DoT chip fabrication, targeting completion by Q4 2025, supported by a strategic partnership and expanded engineering teams across multiple continents.

Adisyn Ltd has initiated a pivotal phase in its graphene interconnect technology development, commissioning a state-of-the-art Atomic Layer Deposition system and collaborating globally to tackle semiconductor bottlenecks.

Vmoto reports a sharp 44% decline in 2Q25 sales driven by China’s slowdown but counters with strategic UK investment and a new Uber partnership to electrify European delivery fleets.

Nutritional Growth Solutions revises its Q2 FY25 financials, confirming stable revenue and detailing expanded distribution into CVS and Walmart. The company is actively raising capital to support growth and improve liquidity.

Firebird Metals has received a significant Expression of Interest from Taza Metal Technologies to purchase up to five of its energy-efficient kilns, potentially generating over US$10 million in revenue. This marks a key step in Firebird’s international commercial expansion and highlights its leadership in sustainable manganese processing technology.

Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.

Telix Pharmaceuticals has recast its historical financials from AUD to USD to better reflect its US-centric revenue streams and reports increased operating expenditure tied to recent acquisitions and growth initiatives.

Austal Limited has raised its FY2025 EBIT guidance from $80 million to at least $100 million, driven by robust manufacturing performance and a key submarine modules contract with General Dynamics Electric Boat.

Element 25 Limited is advancing its Butcherbird Manganese Mine expansion in Western Australia alongside a new US-based refinery, backed by strong financing and partnerships with major automakers for EV battery-grade manganese supply.

Imagion Biosystems has raised A$3.5 million through a placement to fund its Phase 2 clinical trial for HER2+ Breast Cancer in the US, marking a significant step in advancing its proprietary MagSense® imaging technology.

Western Yilgarn Limited has announced a significant discovery of high-grade surface gallium mineralisation at its Ida Holmes Junction Project in Western Australia, highlighting the project's potential in the critical minerals sector.

Rhythm Biosciences has advanced its ColoSTAT® diagnostic kits to final production validation, demonstrating consistent detection of colorectal cancer across all stages in a pivotal study. The company is gearing up for regulatory submission and commercial launch later this year.